 HOUSTON, May 07, 2021 GLOBE NEWSWIRE -- Bio-Path Holdings, Inc., NASDAQ: BPTH a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, May 14, 2021 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2021 and to provide a business overview. 